India · Delayed Price · Currency is INR Sudeep Pharma Statistics
Total Valuation
Sudeep Pharma has a market cap or net worth of INR 75.49 billion. The enterprise value is 76.39 billion.
| Market Cap | 75.49B |
| Enterprise Value | 76.39B |
Important Dates
The last earnings date was Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sudeep Pharma has 112.95 million shares outstanding. The number of shares has increased by 0.70% in one year.
| Current Share Class | 112.95M |
| Shares Outstanding | 112.95M |
| Shares Change (YoY) | +0.70% |
| Shares Change (QoQ) | +1.57% |
| Owned by Insiders (%) | 37.13% |
| Owned by Institutions (%) | 14.28% |
| Float | 25.44M |
Valuation Ratios
The trailing PE ratio is 43.42.
| PE Ratio | 43.42 |
| Forward PE | n/a |
| PS Ratio | 12.23 |
| PB Ratio | 10.22 |
| P/TBV Ratio | 11.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 45.42 |
| EV / Sales | 12.37 |
| EV / EBITDA | 34.73 |
| EV / EBIT | 37.38 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.65 |
| Debt / FCF | n/a |
| Interest Coverage | 30.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 19.12% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 12.86M |
| Profits Per Employee | 3.50M |
| Employee Count | 740 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Sudeep Pharma has paid 533.03 million in taxes.
| Income Tax | 533.03M |
| Effective Tax Rate | 23.88% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 621.05 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 64.50 |
| Average Volume (20 Days) | 113,010 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sudeep Pharma had revenue of INR 6.17 billion and earned 1.68 billion in profits. Earnings per share was 15.40.
| Revenue | 6.17B |
| Gross Profit | 3.91B |
| Operating Income | 2.04B |
| Pretax Income | 2.23B |
| Net Income | 1.68B |
| EBITDA | 2.19B |
| EBIT | 2.04B |
| Earnings Per Share (EPS) | 15.40 |
Balance Sheet
The company has 676.19 million in cash and 1.43 billion in debt, with a net cash position of -751.02 million or -6.65 per share.
| Cash & Cash Equivalents | 676.19M |
| Total Debt | 1.43B |
| Net Cash | -751.02M |
| Net Cash Per Share | -6.65 |
| Equity (Book Value) | 7.39B |
| Book Value Per Share | 66.50 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 63.38%, with operating and profit margins of 33.10% and 27.24%.
| Gross Margin | 63.38% |
| Operating Margin | 33.10% |
| Pretax Margin | 36.15% |
| Profit Margin | 27.24% |
| EBITDA Margin | 35.48% |
| EBIT Margin | 33.10% |
| FCF Margin | n/a |
Dividends & Yields
Sudeep Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.70% |
| Shareholder Yield | -0.70% |
| Earnings Yield | 2.23% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |